The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Levodopa-induced psychosis: a kindling phenomenon
Abstract
Of 88 patients with idiopathic Parkinson's disease, without prior psychotic symptoms, and without significant dementia, nearly half had experienced vivid dreams, hallucinations, illusions, and nonconfusional as well as confusional psychoses as side effects of chronic levodopa therapy within the previous year of treatment. It was found that 61.3% of all hallucinations were associated with preexistent or concurrent vivid dream phenomena, that all psychotic states were associated with preexistent or concurrent vivid dreams and/or hallucinations, and that nonconfusional psychotic states tended to become confusional. These findings raise the possibility that chronic levodopa therapy may result in dopaminergic kindling and support the hypothesis that chronic dopaminergic agonism may, via such a kindling mechanism, play a role in the development of some types of psychoses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A permanent change in brain function resulting from daily electrical stimulation
Goddard, G. V., McIntyre, D. C., & Leech, C. K. (1969) · Experimental Neurology · doi:10.1016/0014-4886(69)90128-9 · Cited by 3,052
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Stevens, J. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200020023003 · Cited by 722
Psychiatric Aspects of Neurologic Disease
Plum, F. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500050064028 · Cited by 672
L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.
Barbeau, A. (1969) · PubMed · Cited by 410
Bloom, F. E., Costa, E., & Salmoiraghi, G. C. (1965) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27177-4 · Cited by 407
Victor, M. (1974) · Neurology · doi:10.1212/wnl.24.3.299 · Cited by 360
Amphetamines and Related Compounds
Burger, A. (1971) · Journal of Medicinal Chemistry · doi:10.1021/jm00283a900 · Cited by 344
Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
Andén, N.-E., & Stock, G. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10025.x · Cited by 291
The action of dopamine on neurones of the caudate nucleus
McLennan, H., & York, D. H. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008175 · Cited by 283
Cited by
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
The reinterpretation of dreams: An evolutionary hypothesis of the function of dreaming
Revonsuo, A. (2000) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004015 · Cited by 676
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528
Lieberman, A., Dziatolowski, M., Kupersmith, M., Serby, M., Goodgold, A., Korein, J., & Goldstein, M. (1979) · Annals of Neurology · doi:10.1002/ana.410060409 · Cited by 370
Sleep disorders and sleep effect in Parkinson's disease
Factor, S. A., McAlarney, T., Sanchez‐Ramos, J. R., & Weiner, W. J. (1990) · Movement Disorders · doi:10.1002/mds.870050404 · Cited by 358
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 348
Prospective study of hallucinations and delusions in Parkinson's disease
Holroyd, S. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.734 · Cited by 345
Visual hallucinations in Parkinson's disease: a review and phenomenological survey
Barnes, J. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.727 · Cited by 340
Visual Hallucinations Associated With Parkinson Disease
Sanchez-Ramos, J. R., Ortoll, R., & Paulson, G. W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550120077019 · Cited by 324
Hallucinations in Parkinson disease
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312
Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2005) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290
Organic Delusions: Phenomenology, Anatomical Correlations, and Review
Cummings, J. L. (1985) · British Journal of Psychiatry · doi:10.1192/bjp.146.2.184 · Cited by 284
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
Reading, P. J., Luce, A. K., & McKeith, I. G. (2001) · Movement Disorders · doi:10.1002/mds.1204 · Cited by 272
Gold, K., & Rabins, P. V. (1989) · Comprehensive Psychiatry · doi:10.1016/0010-440x(89)90122-3 · Cited by 256
Psychiatric aspects of Parkinson?s disease: An Update
Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200
Auditory hallucinations in Parkinson's disease
Inzelberg, R., Kipervasser, S., & Korczyn, A. D. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.533 · Cited by 179
Williams-Gray, C. H., Foltynie, T., Lewis, S. J. G., & Barker, R. A. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00004 · Cited by 147
Dream phenomena induced by chronic Levodopa therapy
Sharf, B., Moskovitz, C., Lupton, M. D., & Klawans, H. L. (1978) · Journal of Neural Transmission · doi:10.1007/bf01579073 · Cited by 137
Self-citationA questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B. K., Nation, D., Guevara, A., & Levin, B. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-21 · Cited by 111
Lenka, A., Jhunjhunwala, K. R., Saini, J., & Pal, P. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.005 · Cited by 106
Sleep Disorders in Patients with Parkinson??s Disease: Epidemiology and Management
Larsen, J. P., & Tandberg, E. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00002 · Cited by 102
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
Pagonabarraga, J., Bejr-Kasem, H., Martinez-Horta, S., & Kulisevsky, J. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00918-8 · Cited by 69
Onofrj, M., Thomas, A., & Bonanni, L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1731 · Cited by 41
Treatment of behavioural symptoms and dementia in Parkinson's disease
Hanagasi, H. A., & Emre, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00317.x · Cited by 24
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1978-06-01
- Volume
- 135
- Issue
- 6
- Pages
- 669-675
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W184247467
- Cited by
- 326
- References
- 30
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.